Navigation Links
Deborah Morosini, MD Pathologist and Patient Advocate Signs on as Medical Director and Advisory Board Member of Store-A-Tooth™ Dental Stem Cell Banking
Date:2/5/2013

Lexington, MA (PRWEB) February 05, 2013

Provia Labs’ Store-A-Tooth™, a stem cell bank, specializing in dental stem cell preservation, announces the appointment of Deborah Morosini to their advisory board as Medical Director, further enhancing the company’s team of scientific experts. Dr. Morosini brings both her personal family experience supporting and promoting stem cell research, along with her medical background, to the new role.

Dr. Morosini, an MD Pathologist, who also has a Master’s Degree in Social Work, is a voice for cancer patients and strong supporter of stem cell research. She was inspired by the philanthropic efforts of her sister Dana Reeve, a non-smoker who died from lung cancer and her brother-in-law Christopher Reeve, the late actor who played Superman, who had a passion for stem cell research for spinal cord injuries and other illnesses. After seeing their admirable work, Morosini incorporated medical and philanthropic synergies in her career, spending the past 10 years as a biotech and pharmaceutical professional, and becoming a noted, inspirational speaker to families dealing with medical hardships.

“As a scientist, I have seen that certain types of mesenchymal stem cells, such as those derived from bone marrow, already provide cures for diseases, and there is significant potential for cells extracted from dental pulp,” said Morosini. “As an individual, and through Chris and Dana’s activism, I also see that hope and passion can fuel the progress in the medical field. Therefore, I applaud the efforts of Provia Labs, offering hope through dental stem cell banking; I’m excited to be a part of their team.”

In her role as Medical Director, Dr. Morosini will review the Company’s specimen collection and sample handling procedures, as well as provide strategic input on potential new scientific breakthroughs in application to dental stem cells. She will be available for scientific literacy and speaking engagements to community groups and physicians.

"We are thrilled to have on our team someone with Dr. Morosini’s experience, influence, and commitment to the advancements of technologies that strongly impact patient care,” said Provia Labs CEO Howard Greenman. “Dr. Morosini joining Provia Labs is continued validation of our technology and mission to advance the use of stem cell technology."

Peter Verlander, PhD and chief scientific officer of Provia Labs added, “Dr. Morosini is a wonderful addition to the Provia team, bringing not only her strong professional background, but her energy, enthusiasm, and commitment to patient advocacy. As medical director, Dr. Morosini will help ensure that Provia's policies and procedures continue to conform to the highest standards.”

Morosini joins Store-A-Tooth following her position with AstraZeneca Pharmaceuticals working in the area of research and development of cancer drugs and strategies. Additionally she has contributed to the development of a data element taxonomy (DET) of disease models for use by genomic researchers as part of the federal government’s National Institute of Standards and Technology Program. Complementing her extensive work in science and medicine, Dr. Morosini is a devoted advocate, spokesperson and philanthropist for the lung cancer community.

About Provia Laboratories, LLC
Provia Laboratories, LLC (http://www.provialabs.com) is a health services company specializing in high quality stem cell biobanking (the collection, transport, processing, and cryogenic storage of biological specimens). Its dental stem cell banking service, Store-A-ToothTM, gives parents the option to store stem cells today to protect their children’s health tomorrow. Store-A-Tooth preserves stem cells from baby and wisdom teeth that would otherwise be discarded, so parents can be prepared for advances in stem cell therapies that someday may help treat conditions such as type 1 diabetes, spinal cord injury, heart attack, stroke, and neurological disorders like Parkinson’s and Alzheimer’s.
For more information about Store-A-Tooth™ dental stem cell banking, please call 1-877-867-5753 or visit us at http://www.store-a-tooth.com or ‘Like’ Store-A-Tooth at http://www.facebook.com/storeatooth.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10395435.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quest Diagnostics Clinical Trials Biorepository Accredited by the College of American Pathologists
2. ARUP Laboratories Pathologist, Ronald L. Weiss, MD, Honored With Lifetime Achievement Award for Contributions to Patient Care and Pathology
3. Kitware Provides Mobile Visualization Support for the Visible Patient Project
4. adams & weber GmbH and Ekahau Install a Location and Emergency Call System for Dementia Patients and Staff at Josef-Ecker-Stift in Neuwied
5. Inflamax Research Introduces Electronic Patient Data Acquisition Tablet™ (ePDAT)™ for Real-Time PRO Data Collection
6. Caris Life Sciences nimmt Next-Generation Sequencing zur Verbesserung des evidenzbasierten Tumorprofilierungsservices für Krebspatienten auf
7. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
8. CSL Behring enrolls first patient in global pediatric Phase III pivotal study of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) to treat hemophilia B
9. Could probiotics help HIV patients?
10. Spartan Bioscience Announces 6,000-Patient Study of Personalized Medicine for Cardiac Stents
11. UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) today announced ... 2015. --> --> For ... of $29.3 million, or $0.34 loss per share, compared to a ... the same period in 2014. For the year ended December 31, ... $1.05 loss per share, as compared to a net loss of ...
(Date:2/11/2016)... NEW YORK , Feb. 11, 2016  Bioethics International, ... how medicines are researched, developed, marketed and made accessible to ... BMJ Open had named the publication of the ... for 2015. The publication is also featured as one of ... published in the last year that are most frequently read. ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... dedicated to delivering cutting-edge information focused on the development and manufacture of ... become a premier sponsor of the 2016 BioProcess International Awards – Recognizing ...
(Date:2/11/2016)... BioInformant announces the February 2016 release of its ... and Technologies – Market Size, Segments, Trends, and Projections ... The first and only market research firm ... more than a decade of historical information on all ... type. This powerful 175 page global strategic report contains ...
Breaking Biology Technology:
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 ... healthcare facilities are primarily focused on medical ... that measure point-of-care parameters. Wearable devices that ... a user,s freedom of movement are being ... sensors for human biomedical signal acquisition coupled ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... Potentials of that Rising Market Are you ... new analysis forecasts revenues for checkpoint inhibitors. Visiongain,s ... world market, submarket, product and national level. ... Instead discover what progress, opportunities and revenues those ...
(Date:2/2/2016)... , Feb. 2, 2016   Parabon NanoLabs ... the U.S. Army Research Office and the Defense ... and sensitivity of the company,s Snapshot Kinship ... Mission and, more generally, defense-related DNA forensics.  Although ... capabilities (predicting appearance and ancestry from DNA evidence), ...
Breaking Biology News(10 mins):